Infliximab, marketed under the name Avakine, is a chimeric monoclonal IgG1 antibody that selectively targets and binds to tumor necrosis factor alpha (TNF-??). By inhibiting the interaction between TNF-?? and its receptors (TNFR1 and TNFR2), Infliximab effectively modulates inflammatory responses. This antibody is widely utilized in research focused on autoimmune diseases, chronic inflammatory conditions, and diabetic neuropathy, offering significant potential for elucidating disease mechanisms and therapeutic interventions.
Infliximab, marketed under the name Avakine, is a chimeric monoclonal IgG1 antibody that selectively targets and binds to tumor necrosis factor alpha (TNF-??). By inhibiting the interaction between TNF-?? and its receptors (TNFR1 and TNFR2), Infliximab effectively modulates inflammatory responses. This antibody is widely utilized in research focused on autoimmune diseases, chronic inflammatory conditions, and diabetic neuropathy, offering significant potential for elucidating disease mechanisms and therapeutic interventions.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
